01 Sep Partner Spotlight: Global Resource for Advancing Cancer Education’s (GRACE) Conference
We are delighted to share an opportunity from our partners at Global Resource for Advancing Cancer Education’s (GRACE). If you are coping with cancer and interested in the latest in targeted therapy research, you wont want to miss this event!
Researchers are making advances in molecularly-driven lung cancer seemingly every day. The need for patient education is on-going and ALK+, ROS1, and EGFR lung cancer patients actively seek it.
They will find it at the Global Resource for Advancing Cancer Education’s (GRACE) 2015 Acquired Resistance for Targeted Therapies in Lung Cancer Patient Forum. The event will take place Saturday, Oct. 3, 2015, at the Marriott Waterfront San Francisco.
Patients and their caregivers who attend will hear directly from leaders in targeted therapy research. In addition to presentations and question and answer sessions, attendees will have many opportunities to approach the faculty to speak with them directly. An evening reception after the event will enable additional one-on-ones and give attendees – many of whom know each other from online support groups – a chance to meet in real life.
- Acquired Resistance & Why It Occurs
- Brain as a Sanctuary Site
- Repeat Biopsies and Serum-Based Testing
- Selecting Patients for Immunotherapy
- Quality of Life vs Progression Free Survival – What Are the Most Relevant Endpoints?
- Patient Assistance Programs
- Lung Cancer Survivorship
Additionally, breakouts for ALK/ROS1 patients and EGFR patients will cover issues specific to those patients:
- New Ideas and Treatment Options
- Individual Treatments for Individual Mutations
- Combinations to Prevent & Treat Acquired Resistance
- Drug Sequencing
GRACE has negotiated a group rate for rooms at the Marriott Waterfront San Francisco of $179 per night (request the “GRACE Patient Forum” room rate).
To learn more about GRACE, visit us at www.cancerGRACE.org.